thiethylperazine has been researched along with Liver Diseases in 1 studies
Thiethylperazine: A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)
thiethylperazine : A member of the class of phenothiazines that is perazine substituted by a ethylsulfanyl group at position 2.
Liver Diseases: Pathological processes of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| REBECCHI, M | 1 |
| VACCARI, F | 1 |
1 other study available for thiethylperazine and Liver Diseases
| Article | Year |
|---|---|
[CLINICAL RESEARCH ON A NEW DRUG WITH ANTIEMETIC AND ANTIVERTIGINOUS ACTION].
Topics: Antiemetics; Biomedical Research; Gallbladder Diseases; Humans; Liver Diseases; Meniere Disease; Sto | 1963 |